The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's
talk page or in a
deletion review). No further edits should be made to this page.
The result was no consensus — almost the precise definition of it in fact. It is, as always, open to users to merge or redirect the article, either in line with
WP:BB or a discussion on a relevant talk page.
Stifle (
talk)
08:18, 28 July 2015 (UTC)reply
Despite a whole slew of references, this organisation is vapourware. It has produced no products, has no facilities, and the entire article confirms this. It might, if it is ever approved, begin some sort of production in 2018. Or it might not.
WP:NOTCRYSTAL applies to this vapourware peddler.
FiddleFaddle22:42, 15 July 2015 (UTC)reply
Keep←. The company has gotten a considerable amount of press, as you can see from the references, and it has received commitments for well over $100 million in financing. It has also signed long-term supply agreements with major entities. It is true that production is not scheduled to begin until 2018, but it is expected to be the only American manufacturer, producing 1/4 of the world's supply, of these radioisotopes that are essential for surgery. So, I think that it is notable. BTW, anyone here who is familiar with initiating AfD's, check out this list that contains totally trivial information:
Australia 2020 Summit participants. --
Ssilvers (
talk)
23:03, 15 July 2015 (UTC)reply
Comment That is the most unusual use of
WP:OTHERCRAPEXISTS in a deletion discussion that I have seen for some time. If you think that list needs nomination for deletion please do it. No precedent is ever set by any article for any other. If it were we would have a brutally fast descent into
idiocracy.
No, your assumption is completely wrong. I never used such an argument. The two articles are unrelated and not similar in any way. --
Ssilvers (
talk)
23:29, 15 July 2015 (UTC)reply
Commitments are just that, commitments. But it requires licencing and much else before it is anything other than vapourware. Even jovial comments on its talk page can be very easily interpreted to show this, and that is by supporters of moving the then Draft: article to main namespace.
FiddleFaddle23:10, 15 July 2015 (UTC)reply
Keep, the company is notable given the shortage of Mo-99 and their efforts / research to address that shortage. These efforts have been covered in the national publication
Nature magazine and a cover story from
Nuclear News (PDF), the magazine of the
American Nuclear Society. At least 20+ million dollars in Federal funding has been given to them for development as well.
[1] They are also supported by several US National Nuclear Research facilities as cited in the article. There is routine coverage, several articles each year, in the
Wisconsin State Journal, second largest circulation newspaper in Wisconsin and the company has also been covered several times by the
Milwaukee Journal-Sentinel, largest newspaper in Wisconsin. Even if the facility is never constructed, I think the notability is in the process they developed. --
Dual Freq (
talk)
23:07, 15 July 2015 (UTC)reply
Comment: I would further add to my previous response that the company does have a facility in Monona, Wisconsin, contrary to the nomination statement. It has produced a full-scale demonstration particle accelerator at that facility.
[2] Since they are not licensed by the NRC, they can not create a reaction at this point, but Argonne National Lab demonstrated the SHINE's process for "production, separation and purification of molybdenum-99" and "confirms [the] new commercial method for producing medical isotope".
[3] --
Dual Freq (
talk)
14:44, 18 July 2015 (UTC)reply
Delete or userfy. "SHINE was in the process of . . . " and "The company hopes to . . ." indicate that this article is probably
too soon (if it ever is notable).--
Rpclod (
talk)
03:54, 16 July 2015 (UTC)reply
Comment I have had some time to sample check the references, of which there appear to be a great number. Of the five that I sample checked, and I have only sample checked so far, 100% are regurgitated press releases and PR material, something those of us who have spent a lifetime in marketing can recognise at 50 paces. This smacks of
WP:BOMBARD. We require references from significant coverage about the topic of the article, and independent of it, and in
WP:RS. Doubtless there will be some. If I get the time I will do an analysis of the references, but analysing all 27 will just be busywork. This has escaped from the Draft: namespace approximately three years too early. There looks to be a great PR campaign about who has signed what with them, but this is not significant nor independent coverage.
FiddleFaddle07:29, 16 July 2015 (UTC)reply
The British Pharmacopoeia Commission (2015). British Pharmacopoeia. United Kingdom: TSO Publishers. p. 712.
ISBN978-0-11-322987-1 unable to check, but the text implies that this is not ‘’about SHINE’’, merely about a standard. Probable fail
From this analysis it follows that the majority of the asserted facts in this article are not supported by references that meet Wikipedia’s needs. As it stands this should never have escaped into main namespace. The analysis confirms the desire of a self identified COI editor (my memory says they identified themselves as an intern at SHINE, and this is likely confirmed by the {{connected contributor}} banner on the talk page) to fulfil a job requirement and to get an article published. This is a piece of brochureware supported by
WP:BOMBARD.
On the article talk page editors wonder why folk have not joined in with their conversation about referencing. The answer is that this was a
WP:AFC Draft and the reviews take care of this.
FiddleFaddle08:05, 16 July 2015 (UTC)reply
It's hard not to feel sandbagged since you didn't raise these concerns during a conversation you were obviously watching, since you AfD'd it inside of 90 minutes after it entered main space. You also missed the cover story from
Nuclear News (PDF), the magazine of the
American Nuclear Society that mentions the company and their process. Several of the items you mentioned above are not SHINE press releases, they are from UW-Madison, Los Alamos and Argonne national labs, not written by SHINE. These are major third parties that have partnered with the company. The supply agreements are also written by the other party, GE Healthcare, Lantheus and Deerfield Mgmt, not SHINE. --
Dual Freq (
talk)
11:39, 16 July 2015 (UTC)reply
Comment It was not I who determined that this was fit for main namespace and used the Articles for Creation Helper Script to promote it there, despite its being totally unready to migrate. We require the correct level of assessment of references by reviewers before they take the decision to promote an article. One of the major things reviewers must look for is that a draft should have a 60% chance of surviving an immediate deletion discussion. Some lower that to 50%. You may choose to feel sandbagged if you so desire, but
WP:BURDEN was on the contributing editor to produce correct referencing, and, to a great extent, upon you as the accepting reviewer.. I see this article in this state as having less than even the 50%. It should have remained as a draft and been reviewed properly. It was not. Now it is equal with all other articles here and will sink or swim according to this discussion and others like it.
FiddleFaddle12:36, 16 July 2015 (UTC)reply
I stand by the decision to move it, but regardless of your comment above, it would have been a common courtesy for you to have mentioned in the discussion that you intended to AFD it 90 minutes after it was moved. There are several legitimate sources and third party items you are simply dismissing. In the last 9 years of editing, I've seen much worse than this article at it's current stage. It may not be the best, but the article subject does exist and it's activities are routinely mentioned in regional media. --
Dual Freq (
talk)
00:22, 17 July 2015 (UTC)reply
Comment no. 10 is a technical report, not peer-reviews but subjected to agency review before being published. No 11 is a conference presentation, also not peer reviewed, but anything out of LANL will have ben reviewed internally and can be assumed accurate. They prove that whatever the papers say was indeed done. DGG (
talk )
12:26, 16 July 2015 (UTC)reply
Merge into
Technetium-99m. Normally, no matter how promising the technology , a company producing a new product is not notable until it has produced the product, or at least licensing is completed. The best explanation of this is in the reference just supplied from Nuclear News. I don't see how the peer-reviewed nature of the references is relevant one way or the other. DGG (
talk )
12:26, 16 July 2015 (UTC)reply
Comment: Good afternoon, I am going over all the comments here, but would like to note this regarding references #10 - the national labs are the most credible research facilities in the US.[1] They are a non-biased institutions that is backed by the US government. Also another question, regarding reference number 14: I was instructed during one review that I could not use Deerfield as a "reference" because it was promoting their company. Thank you for the comments, they are very helpful! --
User:PattiMoly99 16 July 2015
There is nothing wrong with number 14. Even if Yahoo Finance published the press release without changes, it would be OK under
WP:SELFPUB, as it is used only to support the claim that the agreement was made. --
Ssilvers (
talk)
21:27, 16 July 2015 (UTC)reply
I am working on finding the sources for anything that appears to be a press release prior to July of 2012 - before my position as Executive Assistant. Hoping to have finished by Wednesday of next week. Any help would be appreciated. Thank you and have a nice weekend. — Preceding
unsigned comment added by
PattiMoly99PattiMoly99 (
talk) 21:04, 17 July 2015 (UTC) (
talk •
contribs)
20:22, 17 July 2015 (UTC)reply
Delete on the borderline of soon becoming notable. The attempt to get the article first is promotional, which is the reason why someone else whould write the article when it becomes notable, and why I do not recommend moving it to draft space. DGG (
talk )
05:13, 19 July 2015 (UTC)reply
Delete, revisit in 2018 There are enough sources to establish the company's technology as notable. There should be a place for that on a page for the most relevant isotopes or processes. The business deals and plans of are all too
WP:CRYSTALBALL for an independent article at this time.
Rhoark (
talk)
21:57, 20 July 2015 (UTC)reply
Keep All the editors seem to agree that it has had widespread coverage, so that means it is notable. The Crystal Ball objection is misguided. It is used when someone claims a topic will receive widespread coverage in the future. We have an article about SETI now for example, we do not need to wait until they find something first.
TFD (
talk)
22:30, 20 July 2015 (UTC)reply
Keep or Merge into
Technetium-99m or other suitable target. - This particular company may fail in its venture, but the impending technetium shortage is real and is very important. For a paper that reviews more than one idea for making up the shortfall see
this Nature article from 2013. It mentions five proposals including SHINE. A related topic of interest is the American Medical Isotopes Production Act of 2011 (signed into law on 2 January 2013), per
this link. That article states there was an actual disruption of medical procedures in 2009-2010 due to the shortage. If somehow the effort of merging the articles would be too great I don't see much problem with retaining the current article, which is not excessively promotional. The lead is OK, and the second paragraph talks about where they are with respect to milestones. Even if the whole company is just the N+1st flaky technology that may never succeed, this article is bare minimum coverage and doesn't promise the moon.
EdJohnston (
talk)
19:03, 23 July 2015 (UTC)reply
Because of the edits performed in
this gross diff I can now see that sufficient notability has been established for me to withdraw my nomination, and, further, to opine Keep in the discussion. My withdrawal should not stop the discussion from running to term since I am simply one person with one opinion. I am basing my mind change on the fact that I can now see that it passes
WP:GNG on the basis that notability is asserted and it either is referenced or is capable of being referenced.
FiddleFaddle19:56, 23 July 2015 (UTC)reply
Keep I just finished a pretty much complete re-write of the article. There's certainly sufficient 3rd party support and relevance within the medical isotope production economy to support retention of the article. --User:Ceyockey (talk to me)
00:08, 25 July 2015 (UTC)reply
Your edits made the company seem too much like they already are in production; the edits failed to take into account that this company may never get off the ground. Which is also why many of us have said "not yet."
Jytdog (
talk)
13:25, 25 July 2015 (UTC)reply
I made it quite clear (except for one mistaken phrase in the opening which you fixed) that they are not producing anything yet and that all their funding is from VC or government with no revenue stream yet. --User:Ceyockey (talk to me)
15:30, 25 July 2015 (UTC)reply
Delete, looks like the company is right on the borderline of notability, but right now it is still in
WP:CRYSTALBALL country. I'd allow it to be put into user draft space (userfied).
Ghostwheelʘ02:33, 26 July 2015 (UTC)reply
Ceyockey, I hope this is allowed, but it wasn't the Netherlands that was idle for sometime that caused such a shortage in the U.S.; It was the NRU reactor in Canada. Here is the reference [1]. Also, we are not a "medical" business, more of a pharmaceutical - I hope I didn't put the "medical" category on there. Thank you for your help!!!
Comment: The company does not plan to produce any software that I am aware of and the article makes no mention of software. --
Dual Freq (
talk)
21:33, 27 July 2015 (UTC)reply
My mistake - to the closing admin, please disregard my previous comment. (I was too hasty to call this software when I saw the word "vapourware"...) Aerospeed (
Talk)
02:20, 28 July 2015 (UTC)reply
The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's
talk page or in a
deletion review). No further edits should be made to this page.
The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's
talk page or in a
deletion review). No further edits should be made to this page.
The result was no consensus — almost the precise definition of it in fact. It is, as always, open to users to merge or redirect the article, either in line with
WP:BB or a discussion on a relevant talk page.
Stifle (
talk)
08:18, 28 July 2015 (UTC)reply
Despite a whole slew of references, this organisation is vapourware. It has produced no products, has no facilities, and the entire article confirms this. It might, if it is ever approved, begin some sort of production in 2018. Or it might not.
WP:NOTCRYSTAL applies to this vapourware peddler.
FiddleFaddle22:42, 15 July 2015 (UTC)reply
Keep←. The company has gotten a considerable amount of press, as you can see from the references, and it has received commitments for well over $100 million in financing. It has also signed long-term supply agreements with major entities. It is true that production is not scheduled to begin until 2018, but it is expected to be the only American manufacturer, producing 1/4 of the world's supply, of these radioisotopes that are essential for surgery. So, I think that it is notable. BTW, anyone here who is familiar with initiating AfD's, check out this list that contains totally trivial information:
Australia 2020 Summit participants. --
Ssilvers (
talk)
23:03, 15 July 2015 (UTC)reply
Comment That is the most unusual use of
WP:OTHERCRAPEXISTS in a deletion discussion that I have seen for some time. If you think that list needs nomination for deletion please do it. No precedent is ever set by any article for any other. If it were we would have a brutally fast descent into
idiocracy.
No, your assumption is completely wrong. I never used such an argument. The two articles are unrelated and not similar in any way. --
Ssilvers (
talk)
23:29, 15 July 2015 (UTC)reply
Commitments are just that, commitments. But it requires licencing and much else before it is anything other than vapourware. Even jovial comments on its talk page can be very easily interpreted to show this, and that is by supporters of moving the then Draft: article to main namespace.
FiddleFaddle23:10, 15 July 2015 (UTC)reply
Keep, the company is notable given the shortage of Mo-99 and their efforts / research to address that shortage. These efforts have been covered in the national publication
Nature magazine and a cover story from
Nuclear News (PDF), the magazine of the
American Nuclear Society. At least 20+ million dollars in Federal funding has been given to them for development as well.
[1] They are also supported by several US National Nuclear Research facilities as cited in the article. There is routine coverage, several articles each year, in the
Wisconsin State Journal, second largest circulation newspaper in Wisconsin and the company has also been covered several times by the
Milwaukee Journal-Sentinel, largest newspaper in Wisconsin. Even if the facility is never constructed, I think the notability is in the process they developed. --
Dual Freq (
talk)
23:07, 15 July 2015 (UTC)reply
Comment: I would further add to my previous response that the company does have a facility in Monona, Wisconsin, contrary to the nomination statement. It has produced a full-scale demonstration particle accelerator at that facility.
[2] Since they are not licensed by the NRC, they can not create a reaction at this point, but Argonne National Lab demonstrated the SHINE's process for "production, separation and purification of molybdenum-99" and "confirms [the] new commercial method for producing medical isotope".
[3] --
Dual Freq (
talk)
14:44, 18 July 2015 (UTC)reply
Delete or userfy. "SHINE was in the process of . . . " and "The company hopes to . . ." indicate that this article is probably
too soon (if it ever is notable).--
Rpclod (
talk)
03:54, 16 July 2015 (UTC)reply
Comment I have had some time to sample check the references, of which there appear to be a great number. Of the five that I sample checked, and I have only sample checked so far, 100% are regurgitated press releases and PR material, something those of us who have spent a lifetime in marketing can recognise at 50 paces. This smacks of
WP:BOMBARD. We require references from significant coverage about the topic of the article, and independent of it, and in
WP:RS. Doubtless there will be some. If I get the time I will do an analysis of the references, but analysing all 27 will just be busywork. This has escaped from the Draft: namespace approximately three years too early. There looks to be a great PR campaign about who has signed what with them, but this is not significant nor independent coverage.
FiddleFaddle07:29, 16 July 2015 (UTC)reply
The British Pharmacopoeia Commission (2015). British Pharmacopoeia. United Kingdom: TSO Publishers. p. 712.
ISBN978-0-11-322987-1 unable to check, but the text implies that this is not ‘’about SHINE’’, merely about a standard. Probable fail
From this analysis it follows that the majority of the asserted facts in this article are not supported by references that meet Wikipedia’s needs. As it stands this should never have escaped into main namespace. The analysis confirms the desire of a self identified COI editor (my memory says they identified themselves as an intern at SHINE, and this is likely confirmed by the {{connected contributor}} banner on the talk page) to fulfil a job requirement and to get an article published. This is a piece of brochureware supported by
WP:BOMBARD.
On the article talk page editors wonder why folk have not joined in with their conversation about referencing. The answer is that this was a
WP:AFC Draft and the reviews take care of this.
FiddleFaddle08:05, 16 July 2015 (UTC)reply
It's hard not to feel sandbagged since you didn't raise these concerns during a conversation you were obviously watching, since you AfD'd it inside of 90 minutes after it entered main space. You also missed the cover story from
Nuclear News (PDF), the magazine of the
American Nuclear Society that mentions the company and their process. Several of the items you mentioned above are not SHINE press releases, they are from UW-Madison, Los Alamos and Argonne national labs, not written by SHINE. These are major third parties that have partnered with the company. The supply agreements are also written by the other party, GE Healthcare, Lantheus and Deerfield Mgmt, not SHINE. --
Dual Freq (
talk)
11:39, 16 July 2015 (UTC)reply
Comment It was not I who determined that this was fit for main namespace and used the Articles for Creation Helper Script to promote it there, despite its being totally unready to migrate. We require the correct level of assessment of references by reviewers before they take the decision to promote an article. One of the major things reviewers must look for is that a draft should have a 60% chance of surviving an immediate deletion discussion. Some lower that to 50%. You may choose to feel sandbagged if you so desire, but
WP:BURDEN was on the contributing editor to produce correct referencing, and, to a great extent, upon you as the accepting reviewer.. I see this article in this state as having less than even the 50%. It should have remained as a draft and been reviewed properly. It was not. Now it is equal with all other articles here and will sink or swim according to this discussion and others like it.
FiddleFaddle12:36, 16 July 2015 (UTC)reply
I stand by the decision to move it, but regardless of your comment above, it would have been a common courtesy for you to have mentioned in the discussion that you intended to AFD it 90 minutes after it was moved. There are several legitimate sources and third party items you are simply dismissing. In the last 9 years of editing, I've seen much worse than this article at it's current stage. It may not be the best, but the article subject does exist and it's activities are routinely mentioned in regional media. --
Dual Freq (
talk)
00:22, 17 July 2015 (UTC)reply
Comment no. 10 is a technical report, not peer-reviews but subjected to agency review before being published. No 11 is a conference presentation, also not peer reviewed, but anything out of LANL will have ben reviewed internally and can be assumed accurate. They prove that whatever the papers say was indeed done. DGG (
talk )
12:26, 16 July 2015 (UTC)reply
Merge into
Technetium-99m. Normally, no matter how promising the technology , a company producing a new product is not notable until it has produced the product, or at least licensing is completed. The best explanation of this is in the reference just supplied from Nuclear News. I don't see how the peer-reviewed nature of the references is relevant one way or the other. DGG (
talk )
12:26, 16 July 2015 (UTC)reply
Comment: Good afternoon, I am going over all the comments here, but would like to note this regarding references #10 - the national labs are the most credible research facilities in the US.[1] They are a non-biased institutions that is backed by the US government. Also another question, regarding reference number 14: I was instructed during one review that I could not use Deerfield as a "reference" because it was promoting their company. Thank you for the comments, they are very helpful! --
User:PattiMoly99 16 July 2015
There is nothing wrong with number 14. Even if Yahoo Finance published the press release without changes, it would be OK under
WP:SELFPUB, as it is used only to support the claim that the agreement was made. --
Ssilvers (
talk)
21:27, 16 July 2015 (UTC)reply
I am working on finding the sources for anything that appears to be a press release prior to July of 2012 - before my position as Executive Assistant. Hoping to have finished by Wednesday of next week. Any help would be appreciated. Thank you and have a nice weekend. — Preceding
unsigned comment added by
PattiMoly99PattiMoly99 (
talk) 21:04, 17 July 2015 (UTC) (
talk •
contribs)
20:22, 17 July 2015 (UTC)reply
Delete on the borderline of soon becoming notable. The attempt to get the article first is promotional, which is the reason why someone else whould write the article when it becomes notable, and why I do not recommend moving it to draft space. DGG (
talk )
05:13, 19 July 2015 (UTC)reply
Delete, revisit in 2018 There are enough sources to establish the company's technology as notable. There should be a place for that on a page for the most relevant isotopes or processes. The business deals and plans of are all too
WP:CRYSTALBALL for an independent article at this time.
Rhoark (
talk)
21:57, 20 July 2015 (UTC)reply
Keep All the editors seem to agree that it has had widespread coverage, so that means it is notable. The Crystal Ball objection is misguided. It is used when someone claims a topic will receive widespread coverage in the future. We have an article about SETI now for example, we do not need to wait until they find something first.
TFD (
talk)
22:30, 20 July 2015 (UTC)reply
Keep or Merge into
Technetium-99m or other suitable target. - This particular company may fail in its venture, but the impending technetium shortage is real and is very important. For a paper that reviews more than one idea for making up the shortfall see
this Nature article from 2013. It mentions five proposals including SHINE. A related topic of interest is the American Medical Isotopes Production Act of 2011 (signed into law on 2 January 2013), per
this link. That article states there was an actual disruption of medical procedures in 2009-2010 due to the shortage. If somehow the effort of merging the articles would be too great I don't see much problem with retaining the current article, which is not excessively promotional. The lead is OK, and the second paragraph talks about where they are with respect to milestones. Even if the whole company is just the N+1st flaky technology that may never succeed, this article is bare minimum coverage and doesn't promise the moon.
EdJohnston (
talk)
19:03, 23 July 2015 (UTC)reply
Because of the edits performed in
this gross diff I can now see that sufficient notability has been established for me to withdraw my nomination, and, further, to opine Keep in the discussion. My withdrawal should not stop the discussion from running to term since I am simply one person with one opinion. I am basing my mind change on the fact that I can now see that it passes
WP:GNG on the basis that notability is asserted and it either is referenced or is capable of being referenced.
FiddleFaddle19:56, 23 July 2015 (UTC)reply
Keep I just finished a pretty much complete re-write of the article. There's certainly sufficient 3rd party support and relevance within the medical isotope production economy to support retention of the article. --User:Ceyockey (talk to me)
00:08, 25 July 2015 (UTC)reply
Your edits made the company seem too much like they already are in production; the edits failed to take into account that this company may never get off the ground. Which is also why many of us have said "not yet."
Jytdog (
talk)
13:25, 25 July 2015 (UTC)reply
I made it quite clear (except for one mistaken phrase in the opening which you fixed) that they are not producing anything yet and that all their funding is from VC or government with no revenue stream yet. --User:Ceyockey (talk to me)
15:30, 25 July 2015 (UTC)reply
Delete, looks like the company is right on the borderline of notability, but right now it is still in
WP:CRYSTALBALL country. I'd allow it to be put into user draft space (userfied).
Ghostwheelʘ02:33, 26 July 2015 (UTC)reply
Ceyockey, I hope this is allowed, but it wasn't the Netherlands that was idle for sometime that caused such a shortage in the U.S.; It was the NRU reactor in Canada. Here is the reference [1]. Also, we are not a "medical" business, more of a pharmaceutical - I hope I didn't put the "medical" category on there. Thank you for your help!!!
Comment: The company does not plan to produce any software that I am aware of and the article makes no mention of software. --
Dual Freq (
talk)
21:33, 27 July 2015 (UTC)reply
My mistake - to the closing admin, please disregard my previous comment. (I was too hasty to call this software when I saw the word "vapourware"...) Aerospeed (
Talk)
02:20, 28 July 2015 (UTC)reply
The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's
talk page or in a
deletion review). No further edits should be made to this page.